Literature DB >> 2831400

Localization of a herpes simplex virus neurovirulence gene dissociated from high-titer virus replication in the brain.

R T Javier1, K M Izumi, J G Stevens.   

Abstract

Previous studies with the herpes simplex virus type 1 X type 2 intertypic recombinant RS6 suggested that the genomic region from 0.11 to 0.14 map units is involved in neurovirulence (R. T. Javier, R. L. Thompson, and J. G. Stevens, J. Virol. 61:1978-1984, 1987). To study this further, we isolated an RS6-derived herpes simplex virus intertypic recombinant (R13-1) which has a genetic defect within this area. After inoculation into mouse brains, R13-1 was found to be approximately 10,000-fold less neurovirulent than either the wild-type type 1 or type 2 parental virus. However, R13-1 replicated in the mouse brain to titers resembling those of the wild-type parents. Further comparisons with wild-type counterparts indicated that R13-1 expressed equivalent levels of the enzyme thymidine kinase and replicated to intermediate levels in primary mouse embryo fibroblasts maintained at the normal body temperature for mice. Using marker rescue techniques combined with in vivo selection, we found that recombination between unit-length R13-1 DNA and a cloned type 1 DNA fragment spanning the region from 0.11 to 0.14 map units (EcoRI-d, 0.079 to 0.192 map units) generated viruses with a wild-type neurovirulence phenotype. To further refine the genomic region of interest, we performed marker rescue experiments using two EcoRI-d subclones, EcoRI/BamHI dc (0.079 to 0.143 map units) and BamHI/EcoRI and (0.143 to 0.192 map units), representing the left and right halves of the EcoRI d fragment, respectively. In these experiments the EcoRI/BamHI dc clone, but not the BamHI/EcoRI ad clone, yielded recombinant viruses exhibiting wild-type neurovirulence. These results show that at least one herpes simplex virus gene function associated with neurovirulence is located within a 9.1-kilobase region at 0.079 to 0.143 map units of the viral genome. Perhaps more significantly, the results indicate that this neurovirulence property functions independently of high-titer virus replication in the brain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831400      PMCID: PMC253151          DOI: 10.1128/JVI.62.4.1381-1387.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Induction of thymidine kinase by vaccinia-infected mouse fibroblasts.

Authors:  S KIT; L J PIEKARSKI; D R DUBBS
Journal:  J Mol Biol       Date:  1963-01       Impact factor: 5.469

2.  Hydroxylamine mutagenesis of HSV DNA and DNA fragments: introduction of mutations into selected regions of the viral genome.

Authors:  C T Chu; D S Parris; R A Dixon; F E Farber; P A Schaffer
Journal:  Virology       Date:  1979-10-15       Impact factor: 3.616

3.  Biochemical studies on the herpes simplex virus-specified deoxypyrimidine kinase activity.

Authors:  A T Jamieson; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1974-09       Impact factor: 3.891

4.  Genetic analysis of temperature-sensitive mutants of HSV-1: the combined use of complementation and physical mapping for cistron assignment.

Authors:  S K Weller; D P Aschman; W R Sacks; D M Coen; P A Schaffer
Journal:  Virology       Date:  1983-10-30       Impact factor: 3.616

5.  Physical mapping of herpes simplex virus type 1 ts mutants by marker rescue: correlation of the physical and genetic maps.

Authors:  D S Parris; R A Dixon; P A Schaffer
Journal:  Virology       Date:  1980-01-30       Impact factor: 3.616

6.  Absolute linkage of virulence and central nervous system cell tropism of reoviruses to viral hemagglutinin.

Authors:  H L Weiner; M L Powers; B N Fields
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

7.  High mutation frequency in DNA transfected into mammalian cells.

Authors:  M P Calos; J S Lebkowski; M R Botchan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

8.  Genetic variability of herpes simplex virus: development of a pathogenic variant during passaging of a nonpathogenic herpes simplex virus type 1 virus strain in mouse brain.

Authors:  H C Kaerner; C H Schröder; A Ott-Hartmann; G Kümel; H Kirchner
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

9.  Herpes simplex virus phosphoproteins. II. Characterization of the virion protein kinase and of the polypeptides phosphorylated in the virion.

Authors:  S Lemaster; B Roizman
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

10.  Physical mapping of temperature-sensitive mutations of herpes simplex virus type 1 using cloned restriction endonuclease fragments.

Authors:  B Matz; J H Subak-Sharpe; V G Preston
Journal:  J Gen Virol       Date:  1983-10       Impact factor: 3.891

View more
  10 in total

Review 1.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Latent infections in spinal ganglia with thymidine kinase-deficient herpes simplex virus.

Authors:  T P Leist; R M Sandri-Goldin; J G Stevens
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

3.  Molecular attenuation of vaccinia virus: mutant generation and animal characterization.

Authors:  M S Lee; J M Roos; L C McGuigan; K A Smith; N Cormier; L K Cohen; B E Roberts; L G Payne
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

4.  Neurovirulence of herpes simplex virus types 1 and 2 isolates in diseases of the central nervous system.

Authors:  T Bergström; K Alestig; B Svennerholm; P Horal; B Sköldenberg; A Vahlne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

5.  An intertypic herpes simplex virus helicase-primase complex associated with a defect in neurovirulence has reduced primase activity.

Authors:  I Barrera; D Bloom; M Challberg
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  Three herpes simplex virus type 1 latency-associated transcript mutants with distinct and asymmetric effects on virulence in mice compared with rabbits.

Authors:  G C Perng; D Esmaili; S M Slanina; A Yukht; H Ghiasi; N Osorio; K R Mott; B Maguen; L Jin; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Neurovirulence determinants of genetically engineered Theiler viruses.

Authors:  J L Fu; S Stein; L Rosenstein; T Bodwell; M Routbort; B L Semler; R P Roos
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

8.  Neuron-specific restriction of a herpes simplex virus recombinant maps to the UL5 gene.

Authors:  D C Bloom; J G Stevens
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Herpesvirus-mediated gene delivery into the rat brain: specificity and efficiency of the neuron-specific enolase promoter.

Authors:  J K Andersen; D M Frim; O Isacson; X O Breakefield
Journal:  Cell Mol Neurobiol       Date:  1993-10       Impact factor: 5.046

10.  Inferred father-to-son transmission of herpes simplex virus results in near-perfect preservation of viral genome identity and in vivo phenotypes.

Authors:  Utsav Pandey; Daniel W Renner; Richard L Thompson; Moriah L Szpara; Nancy M Sawtell
Journal:  Sci Rep       Date:  2017-10-20       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.